XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS DESCRIPTION (Narrative) (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 31 Months Ended
Sep. 21, 2023
Jun. 08, 2023
USD ($)
shares
Apr. 14, 2023
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Nov. 10, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
Apr. 02, 2021
$ / shares
Apr. 13, 2020
USD ($)
Business Acquisition [Line Items]                      
Net loss       $ 6,800   $ 6,800          
Net cash used in operating activities           (3,673) $ (6,221)        
Accumulated deficit       (99,075)   (99,075)     $ (92,297)    
Working deficiency       $ 1,100   1,100          
Proceeds from issuance of common stock           $ 2,245 129        
Reverse stock split 0.05                    
Common stock, par value | $ / shares       $ 0.01   $ 0.01     $ 0.01    
AGP 2023 Sales Agreement [Member]                      
Business Acquisition [Line Items]                      
Proceeds from issuance of common stock       $ 1   $ 1          
Aggregate authorized offering price     $ 5,800                
Sale of common stock | shares     25 25   25          
Amount available for future sale of shares pursuant to the sales agreement     $ 3,800 $ 3,800   $ 3,800          
AGP 2023 Sales Agreement [Member] | Maximum [Member]                      
Business Acquisition [Line Items]                      
Proceeds from issuance of common stock     $ 1                
Securities purchase agreement                      
Business Acquisition [Line Items]                      
Proceeds from issuance of common stock   $ 2,000                  
Sale of common stock | shares   206,250                  
Payments of stock issuance costs   $ 200                  
AGP | At The Market Offering Agreement                      
Business Acquisition [Line Items]                      
Proceeds from issuance of common stock       $ 0 $ 100 $ 500 $ 100 $ 15,600      
Common stock, par value | $ / shares                   $ 0.01  
Aggregate authorized offering price                     $ 50,000
Sale of common stock | shares       0 4,251 30,827 4,251 260,128      
Payments of stock issuance costs               $ 500